[Gefitinib in the treatment of refractory non-small cell lung cancer]. [electronic resource]
Producer: 20100427Description: 938-40 p. digitalISSN:- 0253-3766
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Bone Neoplasms -- secondary
- Brain Neoplasms -- secondary
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Diarrhea -- chemically induced
- Disease-Free Survival
- ErbB Receptors -- antagonists & inhibitors
- Exanthema -- chemically induced
- Female
- Follow-Up Studies
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- Lymphatic Metastasis
- Male
- Middle Aged
- Neoplasm Staging
- Quality of Life
- Quinazolines -- adverse effects
- Remission Induction
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.